Megan Ziegler

FDA investigator · also recorded as Mat Oes Megan Ziegler, Id Megan Ziegler

Appears on 7 documents from 2023 to 2026, most often at sites in North Carolina. Most often cites control of microbiological contamination (21 CFR 211.113).

7
Documents on file
8.3
Observations per 483
2023
First seen
2026
Most recent

What they cite most

From 58 observations

Activity by year

2023: 1, 2024: 3, 2025: 2, 2026: 1

Where

North Carolina 2 · Arkansas 1 · Mississippi 1 · New Jersey 1 · Oklahoma 1 · Texas 1

Is Megan Ziegler coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 Houston Rx LLCAug 28, 2026 · Houston, Texas
483 Kobo Products, Inc.May 9, 2025 · South Plainfield, New Jersey
483 Deepwater Chemicals, Inc.Feb 14, 2025 · Woodward, Oklahoma
483 Exela Pharma Sciences, LLCNov 15, 2024 · Lenoir, North Carolina
483 Exela Pharma Sciences LLCNov 4, 2024 · Lenoir, North Carolina
483 Willow Birch Pharma, IncMay 3, 2024 · Taylor, Mississippi
483 SCA Pharmaceuticals, Inc.May 17, 2023 · Little Rock, Arkansas

About this profile

What does Megan Ziegler inspect?

Megan Ziegler appears on 7 documents on file covering 6 sites, most often in North Carolina.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.42 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Megan Ziegler is dated Aug 28, 2026.